IP Library Patent Application 11595593
Patent Application
App. No. 11/595,593

Clinical algorithm for excluding patients identified in virtual imaging

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/595,593
Abstract

Aspects of the invention relate to clinical triage protocols for screening a patient population using virtual imaging techniques, for example, virtual colonoscopy. Methods for increasing the specificity of a virtual imaging procedure are provided. In aspects of the invention, colonic effluents are analyzed using one or more molecular detection assays.

Claims (18)

1 . A clinical algorithm for selecting a patient for invasive testing, the method comprising

performing a virtual colonoscopy on a patient:

collecting a colonic effluent sample from the patient;

performing a molecular assay on the colonic effluent; and

performing an invasive analysis on the patient if the patient is identified as positive for a disease in both the virtual colonoscopy and the molecular assay.

2 . The method of claim 1 , wherein the patient is human.

3 . The method of claim 1 , wherein the molecular assay is performed on the colonic effluent only if the patient is identified as positive in the virtual colonoscopy.

4 . A method for excluding patients from undergoing an invasive colonic testing, the method comprising:

performing a virtual colonoscopy on a population of subjects;

collecting a colonic effluent from each subject in the population;

identifying candidates for invasive colonic testing as those subjects that are positive for indicia of colonic disease in the virtual colonoscopy; and,

excluding candidates from the invasive colonic testing if they are negative in a molecular assay performed on their colonic effluent.

5 . A patient care algorithm comprising:

performing a virtual colonoscopy on a subject;

performing a molecular analysis on a colonic sample obtained from the subject if the virtual colonoscopy is positive

performing an invasive colonic test on the subject if the molecular analysis is positive.

6 . The method of any one of claims 1 - 5 , wherein the molecular assay is an assay capable of detecting one or more abnormal nucleic acids associated with a disease.

7 . The method of claim 6 , wherein the disease is colon cancer.

Assignments (3)
MERGER Recorded Jan 14, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 058738/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: EXACT SCIENCES CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 044119/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2008
From: SHUBER, ANTHONY P.
To: EXACT SCIENCES CORPORATION
Reel/Frame 020424/0838 →